UNIVERSITY OF HONG KONG, THE

The University of Hong Kong specializes in high-containment biomedical research, focusing on the surveillance, epidemiology, and pathogenesis of emerging infectious diseases. Their core capabilities include the establishment and longitudinal monitoring of large-scale human cohorts for acute respiratory illness, the development of robust laboratory platforms for studying emerging viruses, and the collection of human and animal samples. The institution possesses advanced technical expertise in culturing SARS-CoV-2 and other Biosafety Level 2 and 3 human-pathogenic coronaviruses using primary human cells and culture models, as well as conducting in vitro and in vivo testing of anti-coronavirus compounds. The contractor works most frequently with the Department of Health and Human Services, where they provide critical research services related to influenza transmission and viral surveillance. They also maintain professional relationships with the Department of State and the Department of Defense, typically serving as a research collaborator or subrecipient in academic and scientific agreements. Their industry focus is centered on biotechnology research and development, specifically within the realms of physical, engineering, and life sciences. They operate as a specialized provider of scientific and technical services, with a particular vertical focus on infectious disease research, biological product manufacturing, and clinical testing laboratory services. The University of Hong Kong operates as an academic institution with a significant geographic presence in Hong Kong, positioning itself as a strategic international partner for U.S. government health and defense agencies requiring specialized regional surveillance and high-level biosafety laboratory capabilities.